Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Jul;12(7):1186-1192.
doi: 10.4103/1673-5374.211201.

Umbilical cord: an unlimited source of cells differentiable towards dopaminergic neurons

Mahdi Eskandarian Boroujeni  1 , Mossa Gardaneh  1
Affiliations
Review

Umbilical cord: an unlimited source of cells differentiable towards dopaminergic neurons

Mahdi Eskandarian Boroujeni et al. Neural Regen Res. 2017 Jul.

Abstract

Cell replacement therapy utilizing mesenchymal stem cells as its main resource holds great promise for ultimate treatment of human neurological disorders. Parkinson's disease (PD) is a common, chronic neurodegenerative disorder hallmarked by localized degeneration of a specific set of dopaminergic neurons within a midbrain sub-region. The specific cell type and confined location of degenerating neurons make cell replacement therapy ideal for PD treatment since it mainly requires replenishment of lost dopaminergic neurons with fresh and functional ones. Endogenous as well as exogenous cell sources have been identified as candidate targets for cell replacement therapy in PD. In this review, umbilical cord mesenchymal stem cells (UCMSCs) are discussed as they provide an inexpensive unlimited reservoir differentiable towards functional dopaminergic neurons that potentially lead to long-lasting behavioral recovery in PD patients. We also present miRNAs-mediated neuronal differentiation of UCMSCs. The UCMSCs bear a number of outstanding characteristics including their non-tumorigenic, low-immunogenic properties that make them ideal for cell replacement therapy purposes. Nevertheless, more investigations as well as controlled clinical trials are required to thoroughly confirm the efficacy of UCMSCs for therapeutic medical-grade applications in PD.

Keywords: Parkinson's disease; cell replacement therapy; differentiation; dopamine; dopaminergic neurons; mesenchymal stem cells; nerve regeneration; neural regeneration; neuronal; substantia nigra; umbilical cord; ventral mesencephalon.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest: None declared.

References

    1. Aliaghaei A, Gardaneh M, Maghsoudi N, Salehinejad P, Gharib E. Dopaminergic induction of umbilical cord mesenchymal stem cells by conditioned medium of choroid plexus epithelial cells reduces apomorphine-induced rotation in Parkinsonian rats. Arch Iran Med. 2016;19:561–570. - PubMed
    1. Athauda D, Foltynie T. The ongoing pursuit of neuroprotective therapies in Parkinson disease. Nat Rev Neurol. 2015;11:25–40. - PubMed
    1. Baksh D, Yao R, Tuan RS. Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow. Stem Cells. 2007;25:1384–1392. - PubMed
    1. Bankiewicz KS, Plunkett RJ, Kophin IJ, Jacobowitz DM, London WT, Oldfield EH. Transient behavioral recovery in hemiparkinsonian primates after adrenal medullary allografts. Prog Brain Res. 1988;78:543–549. - PubMed
    1. Bianco P, Riminucci M, Gronthos S, Robey PG. Bone marrow stromal stem cells: nature, biology, and potential applications. Stem cells. 2001;19:180–192. - PubMed